<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>8750543</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Monte, E</dc:author>
<dc:author>Vílchez, J J</dc:author>
<dc:author>Casanova, B</dc:author>
<dc:type>Letter</dc:type>
<dc:language>es</dc:language>
<dc:date>1996 Jan 13 </dc:date>
<dc:title xml:lang="es">3,4-diaminopiridina en el tratamiento de síndromes miasténicos. Aspectos prácticos.</dc:title>
<dc:title xml:lang="en">[3,4-diaminopyridine in the treatment of myasthenic syndromes. Practical aspects].</dc:title>
<dc:publisher>Medicina clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
